Figures computed from official regulatory filings — .
Analysttarget 4 USD (+669%) · consensus 5/5 · 1 buy · 0 hold · 0 sell
Ownershipinsiders 1.8% · institutions 4.95% · short 20.6% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Citius Pharmaceuticals, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA-approved product, is a targeted immunotherapy for the treatment of cutaneous T-cell lymphoma. The company's late-stage pipeline includes Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections; Halo-Lido, a corticosteroid-lidocaine topical formulation to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; and NoveCite, a mesenchymal stem cell therapy for the treatment of ARDS. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
12 buys— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Mazur Leonard Ltrack record | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Mazur Leonard Ltrack record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Mazur Leonard Ltrack record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Mazur Leonard Ltrack record | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| HOLUBIAK MYRON Ztrack record | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| HOLUBIAK MYRON Ztrack record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| HOLUBIAK MYRON Ztrack record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| HOLUBIAK MYRON Ztrack record | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Mazur Leonard Ltrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| HOLUBIAK MYRON Ztrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Holuka Eugene Myron | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| MCGRATH DENNIS Mtrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Czuczman Myron | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Dutia Suren G | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| HOLUBIAK MYRON Ztrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Bartushak Jaime | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Webb Carol | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Smith Robert Joseph | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Mazur Leonard Ltrack record | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| HOLUBIAK MYRON Ztrack record | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Mazur Leonard Ltrack record | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| HOLUBIAK MYRON Ztrack record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| HOLUBIAK MYRON Ztrack record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| HOLUBIAK MYRON Ztrack record | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Mazur Leonard Ltrack record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |